Transcriptomic analysis reveals differential gene expression in Aspergillus ustus, suggesting enzyme inhibitors may enhance pigment production.
The Aspergillus ustus pigment production was investigated by introducing different precursor and enzyme inhibitors during the early biosynthesis stages. A comparative transcriptomic analysis was conducted between pigment-producing and non-producing A. ustus strains. Bioinformatics approaches were employed to functionally annotate and perform enrichment analysis of the sequenced genes. Reverse transcription quantitative PCR (RT-qPCR) was used to validate the transcriptome sequencing results. The addition of acetic acid, propionic acid, isoleucine, arginine, methionine and phenylalanine enhanced pigment production, whereas iodoacetamide, dinitrofluorobenzene, P-aminobenzoic acid and imidazole inhibited it. Transcriptomic analysis revealed significant differential gene expression during pigment biosynthesis, including pronounced upregulation of genes related to non-reducing polyketide synthase (NR-PKS). Integrative evidence reveals that A. ustus pigment is synthesized via an iterative type I PKS pathway catalyzed by fungal NR-PKSs, similar to the noranthrone biosynthetic pathway in fungi. RT-qPCR validation showed 80% concordance with the RNA-seq data, confirming the reliability of the transcriptome sequencing.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: